Age, Biography and Wiki

Paul Kielholz was born on 15 November, 1916. Discover Paul Kielholz's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 107 years old?

Popular As N/A
Occupation N/A
Age 108 years old
Zodiac Sign Scorpio
Born 15 November, 1916
Birthday 15 November
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 15 November. He is a member of famous with the age 108 years old group.

Paul Kielholz Height, Weight & Measurements

At 108 years old, Paul Kielholz height not available right now. We will update Paul Kielholz's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Paul Kielholz Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Paul Kielholz worth at the age of 108 years old? Paul Kielholz’s income source is mostly from being a successful . He is from . We have estimated Paul Kielholz's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Paul Kielholz Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1916

Paul Kielholz (15 November 1916 - 25 May 1990) was a Swiss psychiatrist, known mainly for his work on major depression, for example, for his method of overcoming antidepressant resistance by using simultaneous intravenous infusions of clomipramine and maprotiline, together with sulpiride and benzodiazepines.